Search Results - "Tesic, Danka"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review by Janković, Slobodan M, Tešić, Danka, Anđelković, Jelena, Kostić, Marina

    “…Evolocumab is fully human monoclonal antibody which binds to proprotein convertase subtilisin/kexin type 9 (PCSK9), and prevents its blocking effect on…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia by Tesic, Danka, Kostic, Marina, Paunovic, Dusko, Jankovic, Slobodan M

    Published in Kardiologia polska (01-01-2015)
    “…Recent studies have shown that dronedarone is associated with significantly fewer adverse effects and treatment discontinuations, and a trend toward reduced…”
    Get full text
    Journal Article
  4. 4

    Addressing challenges for sustainable healthcare in Central and Eastern Europe by Godman, Brian, Novakovic, Tanja, Tesic, Danka, Oortwijn, Wija, Martin, Antony Paul, Parker, Mark, Haycox, Alan

    “…All European countries face increasing challenges in the provision of equitable and comprehensive healthcare for their citizens in view of a number of factors…”
    Get more information
    Journal Article
  5. 5

    Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis by Jankovic, Slobodan M, Aleksic, Jelena, Rakovic, Sladjana, Aleksic, Aleksandra, Stevanovic, Ivan, Stefanovic-Stoimenov, Natasa, Radosavljevic, Marija, Kostic, Marina, Tesic, Danka, Petrovic, Bojana

    Published in Journal of nephrology (01-07-2009)
    “…Both use of nonsteroidal antiinflammatory drugs (NSAIDs) and chronic renal insufficiency are significant independent risk factors for gastrointestinal…”
    Get more information
    Journal Article
  6. 6
  7. 7